Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa
Clinical trial NCT00063778 · COMPLETED
Trial details
- NCT number
- NCT00063778
- Sponsor
- AlphaVax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-07-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.